Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

22nd Century Group Inc (XXII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 302,902
  • Shares Outstanding, K 124,140
  • Annual Sales, $ 16,600 K
  • Annual Income, $ -13,030 K
  • 36-Month Beta 3.38
  • Price/Sales 18.40
  • Price/Cash Flow N/A
  • Price/Book 3.94
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings -0.03 on 11/09/17
  • Next Earnings Date 08/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2111 Cigarettes

    Tobacco

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.07 +24.15%
on 06/21/18
3.01 -14.62%
on 07/05/18
+0.40 (+18.43%)
since 06/19/18
3-Month
1.92 +33.85%
on 04/24/18
3.01 -14.62%
on 07/05/18
+0.26 (+11.26%)
since 04/19/18
52-Week
1.33 +93.23%
on 07/25/17
4.44 -42.12%
on 01/23/18
+0.95 (+58.64%)
since 07/19/17

Most Recent Stories

More News
22nd Century Reports on New Responses to the FDA's Nicotine Reduction Plan

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, today highlights two important ...

XXII : 2.57 (+5.33%)
Free Technical Reports on 22nd Century Group and Three Additional Biotech Equities

Stock Research Monitor: RGNX, RGLS, and ABEO

XXII : 2.57 (+5.33%)
RGNX : 79.35 (+0.76%)
RGLS : 0.29 (unch)
22nd Century Highlights Public Comments to the FDA's Nicotine Reduction Plan

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, today called attention to comments...

XXII : 2.57 (+5.33%)
Data Projects that Cannabis Legalization Will Continue to Create Vast Monetary Value

According to data provided by the European investment bank, Bryan, Garnier & Co., the legal global cannabis market is expected to grow more than 1,000% over the next decade and could reach USD 140 Billion...

POTND : 0.0200 (+32.45%)
WDDMF : 1.1279 (-0.19%)
XXII : 2.57 (+5.33%)
WMD.VN : 1.500 (+0.67%)
TRTC : 1.7600 (-3.30%)
POTN : 0.3001 (-0.40%)
ZYNE : 10.42 (+2.36%)
22nd Century Announces New Non-GMO, Very Low Nicotine Flue-Cured and Burley Tobacco Varieties

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, announced today that the Company has...

XXII : 2.57 (+5.33%)
22nd Century Group Added to Russell 2000, Russell 3000 and Russell Global Indexes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine tobacco, and hemp/cannabis research, announced...

ACBFF : 5.8000 (-4.13%)
XXII : 2.57 (+5.33%)
Today's Research Reports on Stocks to Watch: 22nd Century Group and Palatin Technologies

NEW YORK, NY / ACCESSWIRE / June 25, 2018 / Both 22nd Century Group and Palatin Technologies saw their shares jump on Friday despite either company announcing any significant news.

XXII : 2.57 (+5.33%)
22nd Century Conducts Three Short-Term Studies in Support of the Company's MRTP Application to the FDA

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine Content tobacco, announced that the Company...

XXII : 2.57 (+5.33%)
22nd Century Group to be Added to Russell 2000, Russell 3000, and Russell Global Indexes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine tobacco, and hemp/cannabis research, announced...

XXII : 2.57 (+5.33%)
International Cannabis Legalization to Spur Global Medical and Recreational Sales

According to a research report provided by European investment bank, Bryan, Garnier & Co., the legal global cannabis market is expected to grow more than 1,000% over the next decade and could reach USD...

CARA : 19.26 (-2.83%)
RVV.VN : 0.195 (+8.33%)
WDDMF : 1.1279 (-0.19%)
GWPH : 148.61 (-0.18%)
XXII : 2.57 (+5.33%)
WMD.VN : 1.500 (+0.67%)
ZYNE : 10.42 (+2.36%)
RVVTF : 0.1370 (-2.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators mostly agree with the trend.

See More Share

Trade XXII with:

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

2nd Resistance Point 2.70
1st Resistance Point 2.64
Last Price 2.57
1st Support Level 2.44
2nd Support Level 2.30

See More

52-Week High 4.44
Fibonacci 61.8% 3.25
Fibonacci 50% 2.88
Last Price 2.57
Fibonacci 38.2% 2.52
52-Week Low 1.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar